Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the clinical trial record.
    Difference
    0.4%
    Check dated 2026-10-24T15:50:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T15:46:29.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T15:43:51.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.6 to v3.7.0. This reflects an update to the page's revision-tracking UI/template, not a modification to the study data or history entries.
    Difference
    0.1%
    Check dated 2026-09-19T18:54:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page shows a revision bump from v3.6.5 to v3.6.6, indicating a backend or UI update; the study history content remains unchanged.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:27.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new history entry on 2026-08-06 adds a 'Study Status' field and Revision: v3.6.5, while the 2026-05-01 entry and Revision: v3.6.4 were removed.
    Difference
    0.3%
    Check dated 2026-08-08T17:06:29.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.